SPK-8011

· Spark Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SPK-8011, covering 2024-12-30 to 2024-12-30. Get the full timeline:

Most recent: Clinical Trial Update: A Gene Transfer Study for Hemophilia A [Phase 1, Phase 2]